Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganoderma lucidum spore powder
- Development stage
- Unknown
- Lead developer
- The First Affiliated Hospital of Zhejiang Chinese Medical University
- Administration
- Oral
01
Overview
Ganoderma lucidum spore powder is a botanical product derived from the reproductive spores of the *Ganoderma lucidum* fungus, commonly known as Lingzhi or Reishi. In clinical oncology, particularly in China, "de-walled" or sporoderm-broken versions are utilized as adjuvant therapies to enhance the efficacy of chemotherapy and mitigate treatment-related side effects. The powder contains bioactive compounds such as Ganoderma polysaccharides and triterpenoids, which are thought to possess immunomodulatory, anti-inflammatory, and potential anti-tumor properties. It is currently being investigated in stage IV gastric cancer to improve progression-free survival, overall survival, and quality of life when combined with standard chemotherapy regimens.
- Brand names
- Fangge
- Other names
- Lingzhi spore powderReishi spore powdersporoderm-broken Ganoderma lucidum spore powderde-walled Ganoderma spore powder
02
Targets
CLEC7A (Dectin-1)TLR4 (Toll-like receptor 4)
Beyond the preview
Go deeper on Ganoderma lucidum spore powder.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ganoderma lucidum spore powder.